148 related articles for article (PubMed ID: 2300816)
1. Suppression of HIV infection in AZT-treated SCID-hu mice.
McCune JM; Namikawa R; Shih CC; Rabin L; Kaneshima H
Science; 1990 Feb; 247(4942):564-6. PubMed ID: 2300816
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.
Kaneshima H; Shih CC; Namikawa R; Rabin L; Outzen H; Machado SG; McCune JM
Proc Natl Acad Sci U S A; 1991 May; 88(10):4523-7. PubMed ID: 1903543
[TBL] [Abstract][Full Text] [Related]
3. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.
Shih CC; Kaneshima H; Rabin L; Namikawa R; Sager P; McGowan J; McCune JM
J Infect Dis; 1991 Mar; 163(3):625-7. PubMed ID: 1995734
[TBL] [Abstract][Full Text] [Related]
4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
5. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.
Pettoello-Mantovani M; Kollmann TR; Raker C; Kim A; Yurasov S; Tudor R; Wiltshire H; Goldstein H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1880-7. PubMed ID: 9303378
[TBL] [Abstract][Full Text] [Related]
6. Infection of the SCID-hu mouse by HIV-1.
Namikawa R; Kaneshima H; Lieberman M; Weissman IL; McCune JM
Science; 1988 Dec; 242(4886):1684-6. PubMed ID: 3201256
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.
Stanley SK; McCune JM; Kaneshima H; Justement JS; Sullivan M; Boone E; Baseler M; Adelsberger J; Bonyhadi M; Orenstein J
J Exp Med; 1993 Oct; 178(4):1151-63. PubMed ID: 8376927
[TBL] [Abstract][Full Text] [Related]
8. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.
Rabin L; Hincenbergs M; Moreno MB; Warren S; Linquist V; Datema R; Charpiot B; Seifert J; Kaneshima H; McCune JM
Antimicrob Agents Chemother; 1996 Mar; 40(3):755-62. PubMed ID: 8851606
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
[TBL] [Abstract][Full Text] [Related]
11. The SCID-hu mouse as a model for HIV-1 infection.
Aldrovandi GM; Feuer G; Gao L; Jamieson B; Kristeva M; Chen IS; Zack JA
Nature; 1993 Jun; 363(6431):732-6. PubMed ID: 8515816
[TBL] [Abstract][Full Text] [Related]
12. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
Taggart BR; Harrington P; Hollingshead M
Antiviral Res; 2004 Jul; 63(1):1-6. PubMed ID: 15196814
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
Alder J; Hui YH; Clement J
Antiviral Res; 1995 May; 27(1-2):85-97. PubMed ID: 7486961
[TBL] [Abstract][Full Text] [Related]
14. Development of a human thymic organ culture model for the study of HIV pathogenesis.
Bonyhadi ML; Su L; Auten J; McCune JM; Kaneshima H
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1073-80. PubMed ID: 8554904
[TBL] [Abstract][Full Text] [Related]
15. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.
Pettoello-Mantovani M; Kollmann TR; Katopodis NF; Raker C; Kim A; Yurasov S; Wiltshire H; Goldstein H
J Infect Dis; 1998 Feb; 177(2):337-46. PubMed ID: 9466519
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of human hematolymphoid function in the SCID-hu mouse.
McCune JM; Péault B; Streeter PR; Rabin L
Immunol Rev; 1991 Dec; 124():45-62. PubMed ID: 1804780
[TBL] [Abstract][Full Text] [Related]
17. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
Kollmann TR; Pettoello-Mantovani M; Zhuang X; Kim A; Hachamovitch M; Smarnworawong P; Rubinstein A; Goldstein H
J Exp Med; 1994 Feb; 179(2):513-22. PubMed ID: 8294863
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
[TBL] [Abstract][Full Text] [Related]
19. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice.
Hesselton RM; Greiner DL; Mordes JP; Rajan TV; Sullivan JL; Shultz LD
J Infect Dis; 1995 Oct; 172(4):974-82. PubMed ID: 7561218
[TBL] [Abstract][Full Text] [Related]
20. Simple i.v. inoculation of HIV-1 to Thy/Liv SCID-hu mice induce reproducible HIV infection with narrowing of medulla in human thymic implant.
Okamoto Y; Ogura A; Shibata S; Amagai T; Katsura Y; Asano T; Honda M
J Vet Med Sci; 1997 Apr; 59(4):259-63. PubMed ID: 9152933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
